INVO: INVO Bioscience Company Sales Revenue

A stable roster of experts contradicts the volatility, yet the product realization trend clearly demonstrates operational efficiency, where the current mark equals 0.01. The INVOcell ecosystem, which ties medical centers to consumables, restores confidence. Revenue is based on the sale of natural conception capsules, which patients choose over expensive IVF.

Revenue and Sales Volume: INVO Bioscience Inc. (INVO) for 07/04/2022 - 04/28/2025

Comprehensive metric breakdowns and analytics for INVO Bioscience Inc. (INVO)

- current price and projected stock value:

Share Price INVO Bio|INVO - Consensus Target

- market capitalization information:

Market Value INVO Bioscience, Inc.|INVO - Total Company Value

- balance sheet net asset value indicators:

Accounting Value per Share INVO Bioscience|INVO - Book Capitalization|Market-to-Book Ratio invobioscience.com|INVO - Company Total Assets

- company liabilities and liquidity data:

- company profitability and valuation multiples indicators:

INVO - Net Income|Expected Net Income INVO Bioscience, Inc.|INVO - P/E Multiple|Projected Price to Earnings Ratio INVO Bio|INVO - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Multiple INVO Bioscience, Inc.|INVO - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) INVO Bioscience|INVO - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months invobioscience.com|INVO - Earnings per share growth in current year|Net earnings per share change forecast for next year INVO Bioscience, Inc.

- company sales and revenue statistics:

INVO - Company Revenue|Company Future Sales Volume INVO Bio|INVO - P/S Multiple|Market Cap to Future Revenue Ratio INVO Bioscience, Inc.

Summary company analysis:INVO invobioscience.com

Analyzing the daily revenue dynamics allows an investor to filter out market noise and assess the actual commercial expansion of the asset. By studying the sales volatility of INVO Bioscience, Inc. (INVO), one can determine the effectiveness of overcoming stringent FDA regulatory barriers and the adoption rates of patented IVF incubators, where stable growth confirms the successful completion of multi-stage medical certification and the expansion of market presence.

Key competitors